glp-1 weight regain The role of glucagon-like peptide-1 receptor agonists in treatment or prevention after bariatric surgery: a systematic review and meta-analysis | Eating and Weight Disorders Heart & Vessels The U.S. health regulator Choose your Option:2-Month Supply

glp-1 weight regain The role of glucagon-like peptide-1 receptor agonists in treatment or prevention after bariatric surgery: a systematic review and meta-analysis | Eating and Weight Disorders Heart & Vessels The U.S. health regulator Choose your Option:2-Month Supply

The U.S. health regulator asked drugmakers to remove label warnings about a potential risk of suicidal thoughts from widely used GLP-1 weight-loss drugs, including Novo Nordisk's Wegovy and Eli Lilly's Zepbound. https://cnn.it/49uSrKw

Patients with a personal history of medullary thyroid carcinoma (MTC) should discuss this with their specialist before considering GLP-1 medications

Heart & Vessels

Choose your Option:2-Month Supply

Notably, in the Researching Cardiovascular Events With a Weekly Incretin in Diabetes (REWIND) trial comparing dulaglutide to placebo, there was an 11% reduction in the incidence of a sustained decline in eGFR of ≥30% (HR, 0.89